PMV Pharmaceuticals, Inc. Annual Income Tax Expense (Benefit) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
PMV Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2018 to 2023.
  • PMV Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was -$16.2M.
  • PMV Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2023 was $2K.
  • PMV Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was -$9K, a 139% decline from 2021.
  • PMV Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2021 was $23K, a 283% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2K +$11K Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 -$9K -$32K -139% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $23K +$17K +283% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $6K -$2K -25% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $8K +$5K +167% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $3K Jan 1, 2018 Dec 31, 2018 10-K 2021-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.